Healthcare · head to head
Clue vs Ibex Medical Analytics

Clue
Healthcare
Period and cycle tracking app owned by German company Biowink, positioned around science based tracking and a published stance against sharing data with law enforcement
- From
- Free
- Rated
- -

Ibex Medical Analytics
Healthcare
Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots
- From
- On request
- Rated
- -
The short version
- Only Clue has a free tier, so it costs nothing to try first.
- Each has a real cost: Clue clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.; Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
- They diverge on capability: Clue covers Cycle and symptom tracking, Ibex Medical Analytics covers Ibex Breast Suite.
- Prices and features above were last checked on 1 September 2026.
Where they differ
Only the attributes on which Clue and Ibex Medical Analytics actually diverge.
| Attribute | Clue | Ibex Medical Analytics |
|---|---|---|
| Starting price | Free | On request |
| Pricing model | Free with a Plus subscription | quote |
| Free tier | Yes | No |
| Platforms | iOS, Android | Web, Cloud, On-premise |
Identical on both: user rating (Not yet rated), category (Healthcare).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in Clue
- Cycle and symptom tracking
- Cycle insights and patterns
- Research partnerships
- EU-based data hosting
- Fertility and conception mode
- Perimenopause and other life stage tracking
Only in Ibex Medical Analytics
- Ibex Breast Suite
- Ibex Prostate
- Ibex Gastric
- Second read safety net
- Prescreening triage
- Heatmap localisation
- Quality reporting
- Scanner-agnostic ingestion
What people use each for
The jobs each tool is most often brought in to do.
Clue
- Someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given Clues EU basis and published stance on law enforcement requestsnot Ibex Medical Analytics
- A user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community contentnot Ibex Medical Analytics
- A buyer comparing Clue directly against Flo on current published privacy policy language before choosing which app to trustnot Ibex Medical Analytics
- Someone tracking perimenopause or other non-standard cycle stages that some period apps do not support wellnot Ibex Medical Analytics
Ibex Medical Analytics
- A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot Clue
- A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot Clue
- A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot Clue
- A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot Clue
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
Clue
- Clues stated policy on not sharing data with law enforcement without a valid legal process is the companys own published position and legal interpretation, not an independent guarantee, and it can still be compelled to comply with a legally binding request under EU or other applicable law.
- Deeper cycle insights and predictions, the features most likely to justify tracking in the first place, are gated behind the Clue Plus subscription rather than fully free.
- Being a smaller company than some competitors, Clue has less capital and legal resource to contest large-scale legal requests than a larger, better-funded rival might, despite its stated intent to do so.
- Research partnerships using anonymised user data, while opt-in, still mean user-derived data can be used in ways beyond direct app functionality, and users should check current consent settings.
- Cycle predictions rely on self-reported data and general population models, so accuracy for irregular cycles or specific medical conditions remains limited regardless of which app is used.
Ibex Medical Analytics
- The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
- It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
- Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
- Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
- Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.
Pricing, plan by plan
Clue
Free- Clue Plus$9.99/month
- Free tier covers core cycle tracking, logging and basic predictions
- Clue Plus adds deeper cycle insights, extended predictions and personalised content
- Annual Plus plans typically offered at a lower effective monthly rate
Ibex Medical Analytics
On request- Ibex clinical applications$undefined/year
- Priced per case analysed under an annual agreement
- Breast, prostate and gastric licensed as separate suites
- Regulatory indication differs between Europe and the United States
Which should you pick?
Choose Clue if
- You need cycle and symptom tracking.
- You want to start without paying.
- You work on iOS, Android.
- You also want cycle insights and patterns.
Choose Ibex Medical Analytics if
- You need ibex breast suite.
- You work on Web, Cloud, On-premise.
- You also want ibex prostate.
Questions people ask
- Is Clue or Ibex Medical Analytics better?
- Neither clearly leads. Clue starts at Free and Ibex Medical Analytics at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, Clue or Ibex Medical Analytics?
- Clue has a free tier; the other does not. Paid plans start at Free for Clue and On request for Ibex Medical Analytics.
- Does Clue or Ibex Medical Analytics run on more platforms?
- Clue runs on iOS, Android. Ibex Medical Analytics runs on Web, Cloud, On-premise.
- Can I use Clue for free?
- Yes. Clue has a free tier, so you can try it without paying. Ibex Medical Analytics starts at On request.
- What is Clue best used for?
- Clue is most often used for someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given clues eu basis and published stance on law enforcement requests, a user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community content, a buyer comparing clue directly against flo on current published privacy policy language before choosing which app to trust, someone tracking perimenopause or other non-standard cycle stages that some period apps do not support well. Of those, someone specifically weighing data jurisdiction and legal exposure when choosing a period tracking app, given clues eu basis and published stance on law enforcement requests and a user who wants cycle tracking positioned around scientific research partnerships rather than lifestyle or community content are not what Ibex Medical Analytics is typically brought in for.
- What can Clue do that Ibex Medical Analytics cannot?
- Clue covers Cycle and symptom tracking, Cycle insights and patterns, Research partnerships, EU-based data hosting. Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net.
Answered from the vendors’ own pages
Clue: Does Clue share data with law enforcement?
Clue publishes a policy stating it does not share health data with law enforcement or public authorities without a legally binding request and states it will challenge requests it considers improper. This is the companys stated position; verify the current policy directly for specifics.
Ibex Medical Analytics: Is Ibex FDA cleared?
The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.
Clue: Why does Clue emphasise being an EU company?
Clue operates under EU GDPR data protection rules and states this legal basis makes it harder for authorities outside the EU, including US authorities, to compel data disclosure than for a company based in the US.
Ibex Medical Analytics: Second read or prescreening?
Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.
Clue: Is Clue free?
Core cycle tracking, logging and basic predictions are free. Deeper insights and extended predictions require Clue Plus.
Ibex Medical Analytics: Does it need a particular scanner?
It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.
Ibex Medical Analytics: What tissue types are covered?
Breast, prostate and gastric. Everything else in the case mix is unsupported.
Related pages
More on Ibex Medical Analytics
Other head to heads
- Clue vs Flo
- Clue vs PioneerRx
- Clue vs Rad AI
- Clue vs Therapixel
- Clue vs Athenahealth
- Clue vs Lyra Health
- Clue vs Koa Health
- Clue vs OpenMRS
- Clue vs Visage Imaging
- Clue vs WebPT
- Clue vs Gleamer
- Clue vs Kareo
- Clue vs Quantum Health
- Clue vs Techcyte
- Clue vs TherapyNotes
- Clue vs Zocdoc
- Clue vs Allscripts Professional EHR
- Clue vs Paige
- Clue vs Sectra
- Clue vs Annalise.ai
- Clue vs PathAI
- Clue vs Lunit
- Clue vs Beckman Coulter DxONE
- Clue vs Ambra Health
- Clue vs Liberty Software
- Clue vs Kareo Clinical
- Clue vs Practice Fusion
- Clue vs Ro
- Clue vs RXNT
- Clue vs Signant Health
- Clue vs Sysmex
- Clue vs Talkspace
- Ibex Medical Analytics vs Flo
- Ibex Medical Analytics vs PioneerRx
- Ibex Medical Analytics vs Rad AI
- Ibex Medical Analytics vs Therapixel
- Ibex Medical Analytics vs Athenahealth
- Ibex Medical Analytics vs Lyra Health
- Ibex Medical Analytics vs Koa Health
- Ibex Medical Analytics vs OpenMRS
- Ibex Medical Analytics vs Visage Imaging
- Ibex Medical Analytics vs WebPT
- Ibex Medical Analytics vs Gleamer
- Ibex Medical Analytics vs Kareo
- Ibex Medical Analytics vs Quantum Health
- Ibex Medical Analytics vs Techcyte
- Ibex Medical Analytics vs TherapyNotes
- Ibex Medical Analytics vs Zocdoc
- Ibex Medical Analytics vs Allscripts Professional EHR
- Ibex Medical Analytics vs Paige
- Ibex Medical Analytics vs Sectra
- Ibex Medical Analytics vs Annalise.ai
- Ibex Medical Analytics vs PathAI
- Ibex Medical Analytics vs Lunit
- Ibex Medical Analytics vs Beckman Coulter DxONE
- Ibex Medical Analytics vs Ambra Health
- Ibex Medical Analytics vs Liberty Software
- Ibex Medical Analytics vs Kareo Clinical
- Ibex Medical Analytics vs Practice Fusion
- Ibex Medical Analytics vs Ro
- Ibex Medical Analytics vs RXNT
- Ibex Medical Analytics vs Signant Health
- Ibex Medical Analytics vs Sysmex
- Ibex Medical Analytics vs Talkspace
